CLINICAL RESPONSE TO A SECOND UTERINE CURETTAGE IN PATIENTS WITH LOW-RISK GESTATIONAL TROPHOBLASTIC DISEASE: A PILOT STUDY

被引：0
作者：
Yarandi, F. [1 ]
Ali, E. Shir [1 ]
机构：
[1] Teharn Univ Med Sci, Tehran, Iran
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2019年 / 29卷
关键词：
D O I：
10.1136/ijgc-2019-ESGO.1187
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP1146
引用
收藏
页码：A595 / A595
页数：1
相关论文
共 50 条
[41]   Methotrexate-induced hemothorax in a woman with low-risk metastatic gestational trophoblastic disease [J].
Ohki, Yuji ;
Yamada, Hisako ;
Taira, Yusuke ;
Kudaka, Wataru ;
Aoki, Yoichi .
GYNECOLOGIC ONCOLOGY REPORTS, 2019, 30
[42]   METHOTREXATE WITH CITROVORUM FACTOR IN LOW-RISK GESTATIONAL TROPHOBLASTIC TUMOR [J].
BOLIS, G ;
COLOMBO, N ;
EPIS, A ;
MANGILI, G ;
VASSENA, L ;
VERGADORO, F ;
BELLONI, C .
TUMORI, 1987, 73 (03) :309-313
[43]   Second Uterine Curettage and the Number of Chemotherapy Courses in Postmolar Gestational Trophoblastic Neoplasia A Randomized Controlled Trial [J].
Hemida, Reda ;
Vos, Elvira L. ;
El-Deek, Basem ;
Arafa, Mohammad ;
Toson, Eman ;
Burger, Curt W. ;
van Doorn, Helena C. .
OBSTETRICS AND GYNECOLOGY, 2019, 133 (05) :1024-1031
[44]   Second Uterine Curettage and the Number of Chemotherapy Courses in Postmolar Gestational Trophoblastic Neoplasia: A Randomized Controlled Trial [J].
Usui, Hirokazu .
OBSTETRICS AND GYNECOLOGY, 2019, 134 (03) :649-649
[45]   Response to single-agent chemotherapy in low-risk gestational trophoblastic neoplasia: a cross-sectional study [J].
Das, Esha ;
Chaturvedula, Latha ;
Ganesan, Prasanth .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) :A334-A334
[46]   Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients: efficacy and toxicity [J].
Chalouhi, Gihad Elias ;
Golfier, Francois ;
Soignon, Pauline ;
Massardier, Jerome ;
Guastalla, Jean-Paul ;
Trillet-Lenoir, Veronique ;
Schott, Anne-Marie ;
Raudrant, Daniel .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 200 (06) :643.e1-643.e6
[47]   Guidelines for the stratification of patients recruited to trials of therapy for low-risk gestational trophoblastic tumor [J].
Nevin, J ;
Silcocks, P ;
Hancock, B ;
Coleman, R ;
Nakielny, R ;
Lorigan, P .
GYNECOLOGIC ONCOLOGY, 2000, 78 (02) :92-96
[48]   Relapse rate of patients with low-risk gestational trophoblastic tumor treated in a single institution [J].
Matsui, H .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :776S-776S
[49]   Treatment of low risk gestational trophoblastic disease [J].
Carney, ME .
CLINICAL OBSTETRICS AND GYNECOLOGY, 2003, 46 (03) :579-592
[50]   Risk factors for second-line dactinomycin failure after methotrexate treatment for low-risk gestational trophoblastic neoplasia: a retrospective study [J].
Hoeijmakers, Y. M. ;
Sweep, F. C. G. J. ;
Lok, C. A. R. ;
Ottevanger, P. B. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2020, 127 (09) :1139-1145
12345